Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized placebo-controlled dose-finding study of epeleuton in adults with hypertriglyceridemia and type 2 diabetes mellitus
MOH_2020-08-03_009212Phase 2Not yet recruiting
- Sponsor
- Afimmune
- Start
- Jul 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epeleuton in hypertriglyceridemia and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Afimmune. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
epeleuton
03
Conditions
hypertriglyceridemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on MOH_2020-08-03_009212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-08-03_009212.